Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Polynucleotide and hyaluronic acid gel with xenogeneic bone graft for treating intrabony periodontal defects

Official title: Effects of the Combination of a Polynucleotide and Hyaluronic Acid-Based Gel With Xenogeneic Bone Graft in the Treatment of Intrabony Defects in Patients With Periodontitis: a Randomized Controlled Clinical Trial.

Run by University of Sao Paulo · NCT07522684 · Data updated 2026-11-12

This study tests whether adding a polynucleotide/hyaluronic acid gel plus a xenogeneic bone graft to open-flap debridement helps adults with stage III/IV periodontitis and intrabony defects heal better.

More Periodontitis trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment66 (estimated)
SponsorUniversity of Sao Paulo
Academic / other
Locations1 site (Ribeirão Preto, São Paulo)
StatusRecruiting
StartedFebruary 25, 2026
Main results expectedMay 2028
Study endsMay 2028
Registry record updatedApril 20, 2026
Trial IDNCT07522684 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) with stage III or IV periodontitis, good plaque and bleeding control (FMPS and FMBS ≤20%), and a single 2- or 3-wall intrabony defect ≥3 mm with PD and CAL ≥5 mm are ideal candidates.

Probably not a fit

Patients with furcation involvement at the defect site, systemic conditions affecting healing, recent antimicrobial use, long-term immunosuppression, or poor oral hygiene are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, parallel-group clinical trial enrolling adults with stage III or IV periodontitis who have a 2- or 3-wall intrabony defect. Participants are randomized 1:1:1 to open-flap debridement alone, open-flap debridement with a xenogeneic bone graft, or open-flap debridement with a xenogeneic graft plus a polynucleotide/hyaluronic acid (PN/HA) gel. The trial is powered to detect a 1 mm difference in clinical attachment level and will measure clinical, radiographic/tomographic, immunologic, and patient-centered outcomes. A total of 66 patients (22 per group) are planned, with standardized surgical procedures and follow-up evaluations at prespecified time points.

Why it matters

Potential benefit: If successful, the combination approach could improve periodontal tissue regeneration and bone fill, potentially improving tooth prognosis and reducing the need for additional treatment.

How similar studies have gone: Xenogeneic bone grafts and hyaluronic acid have prior supportive evidence for helping periodontal repair, but the addition of polynucleotides in this combination is relatively novel and less well tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ≥ 18 years of age;
* diagnosis of periodontitis stage III or IV, grade B or C (Chapple et al., 2018; Papapanou et al., 2018);
* full-mouth plaque score (FMPS) and full-mouth bleeding score (FMBS) of ≤ 20%;
* presence of a 2- or 3-wall intrabony defect with a depth ≥ 3 mm and probing depth and clinical attachment level ≥ 5 mm in the interproximal region of a single- or multi-rooted tooth;
* pulp vitality or satisfactory endodontic treatment in the tooth to be treated;
* at least 1 mm of keratinized tissue on the buccal surface of the tooth to be treated.

Exclusion Criteria:

* presence of furcation involvement associated with the intrabony defect;
* presence of systemic conditions that may affect the progression of periodontitis or the response to its treatment;
* long-term use of anti-inflammatory or immunosuppressive medications;
* use of antimicrobials within the last 6 months;
* continuous use of mouthwashes containing antimicrobial agents within the last 6 months;
* need for prophylactic antibiotic therapy for routine dental procedures;
* current or past tobacco use within the last 5 years;
* pregnancy;
* breastfeeding.

Where it's running

  • Ribeirão Preto School of Dentistry, University of São Paulo
    Ribeirão Preto, São Paulo, Brazil
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.